Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
SAUDI ARABIA –Saudi Arabia’s largest pharmacy retail chain plans to seek US$1.3 billion in an initial public offering in the coming months, Arabian Business has reported, citing sources privy to…
Read More
SAUDI ARABIA – Nahdi Medical Co., Saudi Arabia’s largest pharmacy group, is planning to extend its services into a full range of primary care offerings, including giving access to pharmacists…
Read More
CHINA – Digital healthcare startup, ETAO International Group has announced that it will go public through a merger with a blank-check company, in a deal valued at US$2.5 billion. The…
Read More
USA – Affinia Therapeutics, a preclinical biotech developing novel gene therapies for rare diseases and cancer, filed with the Securities and Exchange Commission (SEC) for an initial public offering of…
Read More
INDIA – GPT Healthcare, a provider of integrated healthcare services, has received approval from the Securities Exchange Board of India (SEBI) to launch its initial public offering (IPO). The Kolkata-based…
Read More
USA – Phressia announced that it has acquired Insignia Health, LLC, a mission-driven company dedicated to improving health outcomes through patient activation. The agreement is a natural extension of the…
Read More
IRELAND – HealthBeacon, an Irish medtech firm, has announced plans to raise up to €25 million (US$28.23 million) through an initial public offering (IPO) on Euronext Dublin’s growth market. This…
Read More
INDIA – MedPlus Health Services Ltd, India’s second-largest pharmacy retailer, announced that the Securities and Exchange Board of India (SEBI) has approved its initial public offering (IPO) to raise up…
Read More
INDIA- PharmEasy, an online drugstore chain, has reportedly raised nearly US$350 million in its most recent round of funding ahead of filing its draft red herring prospectus (DRHP) before an…
Read More
UNITED KINGDOM – Exscientia’s initial public offering and private placement has raised US$464 million to fund its artificial intelligence-based approach to drug discovery and development. The new cash infusion follows…
Read More